Literature DB >> 26283596

Multimodal Nanoparticle for Primary Tumor Delineation and Lymphatic Metastasis Mapping in a Head-and-Neck Cancer Rabbit Model.

Nidal Muhanna1,2, Thomas D MacDonald1,3, Harley Chan1,2, Cheng S Jin1,3,4, Laura Burgess1,5, Liyang Cui1,5,6, Juan Chen1, Jonathan C Irish1,2, Gang Zheng1,3,4,5.   

Abstract

64 Cu-porphysome nanoparticles enable superior delineation of neoplastic tissues, metastatic lymph nodes, and vascular drainage on head and neck cancer orthotopic rabbit model using positron emission tomography imaging. Additionally, the nanoparticles exhibit selective fluorescence activation in tumor and metastatic lymph nodes, which permits intraoperative real-time visualization of disease tissues to precisely define surgical margins and prevents collateral damage during surgeries.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  PET imaging; fluorescence imaging; head and neck cancer; lymph node metastases; porphysome

Year:  2015        PMID: 26283596     DOI: 10.1002/adhm.201500363

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  3 in total

1.  An Integrated Nanotechnology-Enabled Transbronchial Image-Guided Intervention Strategy for Peripheral Lung Cancer.

Authors:  Cheng S Jin; Hironobu Wada; Takashi Anayama; Patrick Z McVeigh; Hsin Pei Hu; Kentaro Hirohashi; Takahiro Nakajima; Tatsuya Kato; Shaf Keshavjee; David Hwang; Brian C Wilson; Gang Zheng; Kazuhiro Yasufuku
Journal:  Cancer Res       Date:  2016-08-19       Impact factor: 12.701

Review 2.  Current trends in pyrrole and porphyrin-derived nanoscale materials for biomedical applications.

Authors:  Parinaz Fathi; Dipanjan Pan
Journal:  Nanomedicine (Lond)       Date:  2020-09-25       Impact factor: 5.307

3.  Use of Porphysomes to detect primary tumour, lymph node metastases, intra-abdominal metastases and as a tool for image-guided lymphadenectomy: proof of concept in endometrial cancer.

Authors:  Lauren Philp; Harley Chan; Marjan Rouzbahman; Marta Overchuk; Juan Chen; Gang Zheng; Marcus Q Bernardini
Journal:  Theranostics       Date:  2019-04-13       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.